CIK 0002079109 · Pharmaceutical Preparations (SIC 2834) · Nasdaq, Nasdaq · incorporated in V8 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-15 | 6-K | 6-K | 2026-10-15 |
| 2026-09-14 | 3 | FORM 3 | 2026-09-01 |
| 2026-09-04 | 424B3 | 424B3 | |
| 2026-09-04 | 424B3 | 424B3 | |
| 2026-09-04 | 6-K | 6-K | 2026-09-04 |
| 2026-08-31 | 4 | FORM 4 | 2026-08-27 |
| 2026-08-31 | 4 | FORM 4 | 2026-08-27 |
| 2026-08-24 | 6-K | 6-K | 2026-08-24 |
| 2026-08-20 | 3 | FORM 3 | 2026-07-10 |
| 2026-08-13 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-10 | 424B5 | 424B5 | |
| 2026-08-10 | 424B5 | 424B5 | |
| 2026-08-06 | EFFECT | EFFECT items ,, | |
| 2026-08-06 | EFFECT | EFFECT items ,, | |
| 2026-08-05 | F-1/A | F-1/A | |
| 2026-08-05 | F-1/A | F-1/A | |
| 2026-07-31 | F-1 | F-1 | |
| 2026-07-31 | F-1 | F-1 | |
| 2026-07-31 | 6-K | 6-K | 2026-07-31 |
| 2026-07-27 | 6-K | 6-K | 2026-07-27 |
| 2026-07-27 | 6-K | 6-K | 2026-07-27 |
| 2026-06-18 | 6-K | 6-K | 2026-06-18 |
| 2026-06-16 | 20-F | 20-F | 2025-12-31 |
| 2026-06-16 | SCHEDULE 13D | SCHEDULE 13D | |
| 2026-06-16 | SCHEDULE 13D | SCHEDULE 13D |
Forms on file (last 1,000): 3 9, 6-K 8, F-4/A 5, SCHEDULE 13D 4, CORRESP 4, 424B3 3, EFFECT 3, UPLOAD 3. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=VRXA (0.002 USD), /gw/filings/filings?ticker=VRXA&form=8-K, /gw/filings/facts?ticker=VRXA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange